Can Pfizer's Stock Break This Disappointing Streak?
(NYSE: PFE) is one of the largest healthcare companies in the world. It was founded in 1849 and has since become an iconic name in healthcare.
It has developed many medicines over the years; most recently, it has been known for developing its highly successful COVID vaccine Comirnaty. Growth and innovation have enabled the company to become a household name and a leader in healthcare.
Investors, however, have been having doubts about the business and its ability to grow in the future. In the past three years, the stock has produced negative returns. Since 2022, It has lost more than half its value. Can the stock break its downward streak, and finish this year in positive territory?
Source Fool.com
Pfizer Inc. Aktie
23,23 €
-0,41 %
Einige mehr Buy-Einschätzungen als Sell-Einschätzungen bei Pfizer Inc..
Mit einem Kursziel von 27 € für Pfizer Inc. ist ein leichter Anstieg gegenüber dem aktuellen Kurs von 23.23 € zu erwarten.
